Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

Aim: So far, the mechanisms behind the cardiovascular benefits of sodium/glucose cotransporter 2 (SGLT2) inhibitors have not been fully clarified. Methods: In order to evaluate the effects of SGLT2 inhibitors on systemic hemodynamics, glucose metabolism, lipid profile, and endothelial function, 50 d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Sawada, Takahiro, Uzu, Kenzo, Hashimoto, Naoko, Onishi, Tetsuari, Takaya, Tomofumi, Shimane, Akira, Taniguchi, Yasuyo, Yasaka, Yoshinori, Ohara, Takeshi, Kawai, Hiroya
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7406405/
https://ncbi.nlm.nih.gov/pubmed/31631099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.50807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados